Ausgabe 3/2008
Inhalt (6 Artikel)
Should the Currently Recommended Twice-Daily Dosing Still be Considered the Most Appropriate Regimen for Treating MRSA Ventilator-Associated Pneumonia with Vancomycin?
Federico Pea, Pierluigi Viale
Antiretroviral Therapy
Sarah M. McCabe, Qing Ma, Judianne C. Slish, Linda M. Catanzaro, Neha Sheth, Robert DiCenzo, Gene D. Morse
Population Pharmacokinetics of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
Arantxazu Isla, Alicia Rodríguez-Gascón, Iñaki F. Trocóniz, Lorea Bueno, María Ángeles Solinís, Javier Maynar, José Ángel Sánchez-Izquierdo, José Luis Pedraz
Application of Basic Pharmacokinetic Concepts to Analysis of Microdialysis Data
Claire Dahyot, Sandrine Marchand, Mikael Bodin, Bertrand Debeane, Olivier Mimoz, William Couet
In Vitro and In Vivo Evaluations of Cytochrome P450 1A2 Interactions with Duloxetine
Evelyn D. Lobo, Richard F. Bergstrom, Shobha Reddy, Tonya Quinlan, Jill Chappell, Quan Hong, Barbara Ring, Mary Pat Knadler
Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban — an Oral, Direct Factor Xa Inhibitor — in Patients Undergoing Major Orthopaedic Surgery
Wolfgang Mueck, Bengt I. Eriksson, Kenneth A. Bauer, Lars Borris, Ola E. Dahl, William D. Fisher, Michael Gent, Sylvia Haas, Menno V. Huisman, Ajay K. Kakkar, Peter Kälebo, Louis M. Kwong, Frank Misselwitz, Alexander G. G. Turpie